Patent ID: 8003661

Claim:
A compound according of Formula I or a pharmaceutically acceptable salt thereof, wherein: X is selected from the group consisting of N or CH; R 1 and R 2 are independently selected from the group consisting of: C 1-6 alkyl, C 3-6 cycloalkyl, and C 1-6 fluoroalkyl; R 3 is selected from the group consisting of: halogen, C 1-6 alkyl and C 1-6 haloalkyl; R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of: hydrogen, halogen, C 1-6 alkyl and C 3-6 cycloalkyl; or R 4 and R 5 or R 6 and R 7 can join to make a 3-6 membered monocyclic cycloalkane ring; Ar is selected from the group consisting of: C 3-6 cycloalkyl, aryl, heteroaryl, and heterocyclyl, or a fused analog of C 3-6 cycloalkyl, aryl, heteroaryl, and heterocyclyl; and each Y is independently selected from the group consisting of: halo, methyl, ethyl, methoxy, CF 3 , CF 3 O— and hydroxy.